BioCentury
ARTICLE | Financial News

Merieux Developpement financial update

November 10, 2014 8:00 AM UTC

Merieux invested EUR70 million ($87.5 million) from its first fund in 12 companies from 2010-14, including neurology company NeuroPhage Pharmaceuticals Inc. (Cambridge, Mass.) and diagnostics company...